Committed to improving the lives of patients

We work to transform the lives of the patients we serve. Meeting their individual needs is what drives our science and provides our focus.

A Global Voyage: Oceans of Hope

Oceans of Hope sails around the world to change the perception of possibility for multiple sclerosis patients.

The stories that inspire our science

Meet some of our patients and hear their stories in their own words

Journalist and Storyteller
"I hope by talking about what I’ve been through I can be an inspiration to the next generation."
Read more
Volunteer and Animal Lover
"I’ve done everything I wanted; I just had to be a little more creative. I want to give others hope that they can do it, too."
Read more
World Traveler and Executive Assistant
"I want people to know that you can do anything you want; you just have to figure out how."
Read more
General Contractor and Business Owner
"If helping others and sharing my story can make the transition to being a patient easier for just one person, I’ve done a good thing."
Read more
Musician and Swimmer
"Having hemophilia has taught me two major lessons by which I live: never waste time and never be afraid to seize an opportunity."
Read more
Volunteer and Small-Business Owner
"When I was first diagnosed, I was very worried that I would have to give up everything that I loved doing, and that I would be alone in a bubble with my MS. I felt isolated, and the uncertainty was huge."
Read more
Swimmer and Volunteer
"Today I focus on what I call ‘the gifts’ MS brought me, like the chance to spend more time with my daughter when she was growing up."
Read more
Loading the player...

Innovative therapies

We develop medicines for debilitating medical conditions with the goal of making a meaningful difference in patients’ lives.

Extending our support in meaningful ways

We believe our therapies can be even more effective when backed by services that support patients emotionally, financially and medically.

Multiple sclerosis (MS) support

  • Multiple sclerosis (MS) support
  • Hemophilia support
  • Partnered therapy support
Multiple sclerosis (MS) support | 1-800-456-2255

Multiple sclerosis (MS) support

As part of our ongoing commitment to people living with multiple sclerosis (MS), Biogen provides extra support through the Above MS™ program.

There are many benefits to joining the Above MS program. Members will get extra help from those who understand MS, including:

  • Specially tailored information from people who are living with relapsing MS, but are also experts in areas such as financial planning, cooking, exercise, and many other areas
  • One-on-one MS support over the phone
  • A community of peers
  • Information about Biogen treatment options and support services
  • Access to Nurse Educators
  • Financial and insurance support if eligible

Join the Above MS program by calling:

Monday – Friday, 8:30 a.m. – 8 p.m. ET

Please keep in mind that a doctor is always the primary resource when it comes to MS and treatment.

Hemophilia support | MyELOCTATE | 1-855-MyELOCTATE MyALPROLIX | 1-855-MyALPROLIX

Hemophilia support

At Biogen, we have listened to the people affected by hemophilia and are providing comprehensive access and assistance programs shaped by community input. We are committed to enabling access to therapy; our goal is for no one to forgo treatment based on financial limitations or insurance status. We offer a variety of personalized assistance and resources through MyELOCTATE™ Services and MyALPROLIX™ Services.

Everyone who calls into MyELOCTATE or MyALPROLIX will talk to a coordinator who will provide dedicated, one-on-one assistance: someone who will work with the individual and tailor resources to help meet their needs. To support access to therapy, these highly trained coordinators will work directly with people with hemophilia, their loved ones, healthcare providers, pharmacies and home healthcare teams. For clinicians, the programs provide a range of professional support materials to facilitate the use of Biogen therapies for appropriate individuals.

Coordinators provide people with hemophilia and their families with:

  • Assistance on how to receive therapy or with monthly out-of-pocket costs
  • Support for continued access to treatment, including if they have a lapse in insurance coverage or have reached their cap
  • A better understanding of their insurance coverage options.

To learn more about these services, please call or visit:

MyELOCTATE – hemophilia A resources
1-855-MyELOCTATE (1-855-693-5628)
Monday–Friday, 8 a.m.–10 p.m. ET

MyALPROLIX - hemophilia B resources
1-855-MyALPROLIX (1-855-692-5776)
Monday–Friday, 8 a.m.–10 p.m. ET

Partnered therapy support | RITUXAN support service | 1-877-474-8892 GAZYVA support service | 1-877-218-3996

Partnered therapy support

RITUXAN® (rituximab) and GAZYVA® (obinutuzumab) patient support is managed by Genentech, a member of Roche Group.

RITUXAN support service

Monday–Friday, 8 a.m.–11 p.m. ET; Saturday, 9 a.m.–1 p.m. ET

GAZYVA support service

24 hours a day, 7 days a week

Multiple sclerosis (MS) support | 1-800-456-2255
Hemophilia support | MyELOCTATE | 1-855-MyELOCTATE MyALPROLIX | 1-855-MyALPROLIX
Partnered therapy support | RITUXAN support service | 1-877-474-8892 GAZYVA support service | 1-877-218-3996

Dedicated to new discoveries

Our pipeline is more than a list of medicines in development. It reflects the work we do here every day to break new ground with science that makes a difference in the lives of patients.

Filter By:
All Therapeutic Areas
  • All Therapeutic Areas
  • Neurology
  • Hematology
  • Immunology
  • Other
All phases
  • All phases
  • Filed
  • Phase 3
  • Phase 2
  • Phase 1
  • 01Phase 1
  • 02 Phase 2
  • 03Phase 3
  • Filed
Currently no results for this search

Gaining insight through clinical trials

Biogen conducts clinical trials to assess new treatments and to investigate potential new uses and benefits for existing therapies.

Clinical trials by Biogen

View clinical trials being conducted by Biogen

Investigators interested in research opportunities

Learn about available research programs for investigators

Learn more about clinical trials

Find out more about our approach to clinical trials

Our perspectives

July 7, 2015


See all perspectives